Reuters logo
BRIEF-Foresee Pharmaceuticals - ‍Co, TRPharm entered exclusive license and distribution agreement
September 27, 2017 / 12:14 PM / 2 months ago

BRIEF-Foresee Pharmaceuticals - ‍Co, TRPharm entered exclusive license and distribution agreement

Sept 27 (Reuters) - Foresee Pharmaceuticals Co Ltd

* Foresee Pharmaceuticals - ‍Co, TRPharm entered exclusive license and distribution agreement

* Foresee Pharmaceuticals - under partnership foresee to receive combination of milestones payments,significant share of product revenue in territory​

* Foresee Pharmaceuticals - agreement for commercialisation in turkey, some middle east countries of Co’s FP-001 program, LMIS subcutaneous depot formulations​

* Foresee Pharmaceuticals Co Ltd - ‍TRPharm will cover all costs for registration and commercialization in territory​ Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below